Home > Income Statement > GLAND PHARMA

GLAND PHARMA
Consolidated Net Profit

    Back to Income Statement
GLAND PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Consolidated Net Profit ₹772 Cr₹781 Cr₹1,212 Cr₹997 Cr₹773 Cr

What is the latest Consolidated Net Profit of GLAND PHARMA ?

The latest Consolidated Net Profit ratio of GLAND PHARMA is ₹772 Cr based on Mar2025 Consolidated results.
Year Consolidated Net Profit
Mar2025₹772 Cr
Mar2024₹781 Cr
Mar2023₹1,212 Cr
Mar2022₹997 Cr
Mar2021₹773 Cr

How is Consolidated Net Profit of GLAND PHARMA Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹772 Cr
-1.10
Mar2024 ₹781 Cr
-35.54
Mar2023 ₹1,212 Cr
21.54
Mar2022 ₹997 Cr
29.00
Mar2021 ₹773 Cr -

Compare Consolidated Net Profit of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹27,785.3 Cr 1.9% -5.9% -4.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹421,131.0 Cr -0.7% -0.5% -3.1% Stock Analytics
DIVIS LABORATORIES ₹171,862.0 Cr 2.9% 1.8% 11.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹129,254.0 Cr 1.5% 3.4% 12.4% Stock Analytics
CIPLA ₹121,198.0 Cr 0.2% -0.2% 0.4% Stock Analytics
DR REDDYS LABORATORIES ₹107,083.0 Cr 0.9% 4.8% -3.2% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

1.9%

-5.9%

-4.9%

SENSEX

1%

0.3%

6.7%


You may also like the below Video Courses